NRX Pharmaceuticals (NRXP) Depreciation and Depletion (2020 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Depreciation and Depletion came in at $20000.0 in Q1 2026, little changed year-on-year from $20000.0 in Q1 2025, and up 100.5% on a QoQ basis from -$4.0 million in Q4 2025.
NRX Pharmaceuticals (NRXP) Depreciation and Depletion (2020 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 7 years of Depreciation and Depletion data on file, last reported at $20000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $20000.0 in Q1 2026; TTM through Mar 2026 was -$2.0 million, a 105.37% decrease from a year earlier, with the FY2025 full-year figure at $10000.0, changed 0.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $20000.0, up from -$4.0 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for NRXP reached as high as $2.0 million in Q3 2025 and fell as low as -$4.0 million in Q4 2025.
- Historically, Depreciation and Depletion has averaged -$184312.5 across 5 years, with a median of $1000.0 in 2022.
- Across the five-year window, Depreciation and Depletion slumped 99100.0% in 2024 and jumped 1900.0% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then slumped by 99100.0% to -$990000.0 in 2024, then tumbled by 303.03% to -$4.0 million in 2025, then jumped by 100.5% to $20000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $20000.0 in Q1 2026, -$4.0 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | -3.99 Mn |
| Dec 31, 2025 | -3.99 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | -990,000.00 |
| Dec 31, 2024 | -990,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |